Halting the Progression of Chronic Nephropathy

R. C. Campbell
2002 Journal of the American Society of Nephrology  
The incidence of end-stage renal disease (ESRD) is increasing worldwide. In the United States alone, there were 372,000 patients requiring renal replacement therapy in the year 2000 and is expected to rise to 650,000 by the year 2010. The trends in Europe and Japan are forecasted to follow a similar path. These increases represent a significant burden to countries worldwide; not only due to the financial costs of providing ESRD care, but also because of lost productivity and significant morbidity and mortality for the affected patients.
doi:10.1097/01.asn.0000032522.29672.0a fatcat:t3i5yerykfhrfjv72pov3andbe